Aehr Test Systems (NASDAQ:AEHR) Issues FY 2024 Earnings Guidance

Aehr Test Systems (NASDAQ:AEHR) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided EPS guidance of 0.480- for the period, compared to the consensus EPS estimate of 0.760. The company issued revenue guidance of $65.0 million-$65.0 million, compared to the consensus revenue estimate of $77.4 million. Aehr Test Systems also updated its Q3 2024 guidance to -0.040–0.030 EPS.

Aehr Test Systems Price Performance

AEHR stock traded down $3.29 during trading hours on Monday, reaching $11.37. The stock had a trading volume of 8,370,435 shares, compared to its average volume of 1,744,823. The stock has a 50-day simple moving average of $16.25 and a 200 day simple moving average of $26.15. The stock has a market capitalization of $328.02 million, a PE ratio of 15.55 and a beta of 2.01. Aehr Test Systems has a fifty-two week low of $10.53 and a fifty-two week high of $54.10.

Aehr Test Systems (NASDAQ:AEHR) last announced its quarterly earnings results on Tuesday, January 9th. The semiconductor company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Aehr Test Systems had a net margin of 25.76% and a return on equity of 26.97%. The business had revenue of $21.43 million for the quarter, compared to analyst estimates of $20.10 million. On average, sell-side analysts forecast that Aehr Test Systems will post 0.72 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on AEHR. William Blair reissued a market perform rating on shares of Aehr Test Systems in a research report on Monday. StockNews.com upgraded Aehr Test Systems from a sell rating to a hold rating in a research report on Friday, January 19th.

Insider Activity

In other news, CEO Gayn Erickson sold 4,871 shares of the firm’s stock in a transaction dated Thursday, January 18th. The stock was sold at an average price of $17.39, for a total transaction of $84,706.69. Following the completion of the transaction, the chief executive officer now directly owns 427,935 shares in the company, valued at $7,441,789.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO Gayn Erickson sold 4,871 shares of the business’s stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $17.39, for a total transaction of $84,706.69. Following the transaction, the chief executive officer now owns 427,935 shares in the company, valued at approximately $7,441,789.65. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Avijit K. Ray-Chaudhuri purchased 3,000 shares of the business’s stock in a transaction on Friday, January 12th. The stock was purchased at an average price of $17.87 per share, for a total transaction of $53,610.00. Following the acquisition, the vice president now owns 9,719 shares of the company’s stock, valued at approximately $173,678.53. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 8,738 shares of company stock valued at $151,723. Insiders own 6.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Ameriprise Financial Inc. purchased a new position in shares of Aehr Test Systems during the 1st quarter valued at $42,623,000. BlackRock Inc. boosted its position in shares of Aehr Test Systems by 253.4% in the second quarter. BlackRock Inc. now owns 1,830,555 shares of the semiconductor company’s stock valued at $75,510,000 after acquiring an additional 1,312,565 shares during the period. State Street Corp lifted its stake in Aehr Test Systems by 236.7% in the 2nd quarter. State Street Corp now owns 553,144 shares of the semiconductor company’s stock worth $22,817,000 after purchasing an additional 388,860 shares in the last quarter. Point72 Asset Management L.P. increased its holdings in shares of Aehr Test Systems by 114.1% in the fourth quarter. Point72 Asset Management L.P. now owns 721,646 shares of the semiconductor company’s stock worth $14,505,000 after purchasing an additional 384,636 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in Aehr Test Systems by 2,389.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 328,192 shares of the semiconductor company’s stock worth $10,185,000 after acquiring an additional 315,009 shares during the last quarter. Hedge funds and other institutional investors own 69.69% of the company’s stock.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.